Genetic Technology Alert. Novel Genetic Approach to Target Pancreatic Cancer Tumor and Regrowth; Genetic Receptor Changes Related to HIV Treatment Identified

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a novel genetic approach to target pancreatic cancer tumor and regrowth, a study to identity genetic receptor changes related to HIV treatment, a study to identity gene types responsible for varying sleep patterns.

Table of Contents

Genetic Technology Alert. Novel Genetic Approach to Target Pancreatic Cancer Tumor and Regrowth; Genetic Receptor Changes Related to HIV Treatment IdentifiedIn This Issue1. NOVEL GENETIC APPROACH TO TARGET PANCREATIC CANCER TUMOR AND REGROWTH2. GENETIC RECEPTOR CHANGES RELATED TO HIV TREATMENT IDENTIFIED3. GENE TYPES RESPONSIBLE FOR VARYING SLEEP PATTERNS IDENTIFIED4. GLOBAL PATENTS ON THE TREATMENT OF ANGELMAN SYNDROME5. TECHVISION 2015




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.